Literature DB >> 7809156

A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells.

B W Cherney1, K Bhatia, G Tosato.   

Abstract

When deprived of autocrine growth factors, Epstein-Barr virus (EBV)-immortalized B cells stop growing and die. In this study, we show that death of EBV-immortalized cells deprived of autocrine growth factors occurred by apoptosis. Cycloheximide, a protein synthesis inhibitor, inhibited apoptosis, suggesting that de novo protein synthesis is required. Because p53, Bcl-2, and c-Myc were previously implicated in the induction or prevention of apoptosis in other systems, we assessed their possible involvement here. Unlike normal cells that respond to growth factor deprivation by down-regulating c-Myc expression, EBV-immortalized cells continued to express c-Myc, p53, and Bcl-2 at levels comparable to those measured prior to starvation. Consistent with data demonstrating that c-Myc expression is sufficient to drive quiescent cells into the cell cycle, autocrine growth factor-deprived EBV-immortalized cells did not undergo growth arrest but rather continued to proliferate until death, which occurred randomly throughout the cell cycle. In contrast to EBV-immortalized B cells, normal peripheral blood B cells activated in vitro with anti-CD40 monoclonal antibody and interleukin 4 rapidly down-regulated c-Myc expression and underwent growth arrest in response to growth factors and serum deprivation. These findings demonstrated that c-Myc expression is deregulated in EBV-immortalized cells. Addition of antisense oligonucleotides to c-Myc specifically promoted the survival of starved EBV-immortalized cells and suppressed growth of nonstarved EBV-immortalized cells. Thus, deregulated expression of c-Myc in EBV-immortalized cells promotes proliferation and apoptosis following autocrine growth factor deprivation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809156      PMCID: PMC45561          DOI: 10.1073/pnas.91.26.12967

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6).

Authors:  G Tosato; K B Seamon; N D Goldman; P B Sehgal; L T May; G C Washington; K D Jones; S E Pike
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

2.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis.

Authors:  G T Williams; C A Smith; E Spooncer; T M Dexter; D R Taylor
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

3.  Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.

Authors:  B A Blazar; L M Sutton; M Strome
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

4.  Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts.

Authors:  L Lombardi; E W Newcomb; R Dalla-Favera
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

5.  Deregulated c-myc expression in Epstein-Barr-virus-immortalized B-cells induces altered growth properties and surface phenotype but not tumorigenicity.

Authors:  N A Hotchin; M J Allday; D H Crawford
Journal:  Int J Cancer       Date:  1990-03-15       Impact factor: 7.396

6.  Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes.

Authors:  L A Sabourin; R G Hawley
Journal:  J Cell Physiol       Date:  1990-12       Impact factor: 6.384

7.  Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by Bcl-2.

Authors:  D L Vaux; I L Weissman
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

8.  Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact.

Authors:  M Dean; R A Levine; W Ran; M S Kindy; G E Sonenshein; J Campisi
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

9.  The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.

Authors:  S Swendeman; D A Thorley-Lawson
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

10.  Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus.

Authors:  J Lacy; W P Summers; W C Summers
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  18 in total

1.  c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release.

Authors:  P Juin; A O Hueber; T Littlewood; G Evan
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

2.  A role for c-myc in chemically induced renal-cell death.

Authors:  Y Zhan; J L Cleveland; J L Stevens
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Statin-induced changes in gene expression in EBV-transformed and native B-cells.

Authors:  Eugene Bolotin; Angela Armendariz; Kyungpil Kim; Seok-Jin Heo; Dario Boffelli; Kelan Tantisira; Jerome I Rotter; Ronald M Krauss; Marisa W Medina
Journal:  Hum Mol Genet       Date:  2013-10-30       Impact factor: 6.150

4.  Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.

Authors:  R Sarid; J S Wiezorek; P S Moore; Y Chang
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity.

Authors:  W Chen; N R Cooper
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state.

Authors:  K D McCullough; J L Martindale; L O Klotz; T Y Aw; N J Holbrook
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 7.  Fas expression and apoptosis in human B cells.

Authors:  E Schattner; S M Friedman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

8.  Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome.

Authors:  Claire E Bocchini; Karen Nahmod; Panagiotis Katsonis; Sang Kim; Moses M Kasembeli; Alexandra Freeman; Olivier Lichtarge; George Makedonas; David J Tweardy
Journal:  Blood       Date:  2016-10-31       Impact factor: 22.113

9.  Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.

Authors:  Cassin Kimmel Williams; Ji-Liang Li; Matilde Murga; Adrian L Harris; Giovanna Tosato
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

10.  Regulation of apoptosis by XIAP ubiquitin-ligase activity.

Authors:  Andrew J Schile; María García-Fernández; Hermann Steller
Journal:  Genes Dev       Date:  2008-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.